Sponsor Pipeline

Lion TCR Pte. Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05195294 Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for… Hepatocellular Carcinoma Not Yet Recruiting
Phase 1
NCT04745403 Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) Hepatocellular Carcinoma Recruiting
NCT06961617 Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma Hepatocellular Carcinoma Recruiting
Disease Areas
Liver Cancer (3)
Get alerts when Lion TCR Pte. Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free